Navigation Links
Renhuang Pharmaceuticals Receives Approval to List on the NYSE Amex
Date:7/1/2010

HARBIN, China, July 1 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced that the Company received approval to list its common stock on the NYSE Amex.

Renhuang expects to begin trading on the NYSE Amex on Friday, July 2, 2010. In connection with the listing on NYSE Amex, Renhuang's stock symbol will change to "CBP" from "RHGP".

"We are very pleased to move onto the NYSE Amex and begin our next phase as a public company," said Mr. Shaoming Li, Chairman of the Board, Chief Executive Officer and President of Renhuang Pharmaceuticals, Inc. "We are honored to join the family of NYSE companies and this is an important milestone in our continuous efforts to raise our profile within the investment community, improve our stock's liquidity, expand our transparency and enhance our corporate governance."

About Renhuang Pharmaceuticals, Inc.

Renhuang Pharmaceuticals, Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and TCM, in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its network of over 3,000 distributors and over 70 sales centers across 24 provinces in

SOURCE Renhuang Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Renhuang Announces Fiscal Year 2010 Guidance
2. Renhuang Announces Price Increase on Shengmai Granules
3. Renhuang Schedules Conference Call to Discuss FY 2010 First Quarter Results
4. Renhuang Pharmaceuticals Announces Continual Improvement in Days Sales Outstanding
5. Renhuang Appoints New Director and Establishes Nominating and Compensation Committee
6. Renhuang Pharmaceuticals Announces Plans to Introduce Qing Re Jie Du Oral Liquid
7. Renhuang Elected as Deputy Chair Unit of Heilongjiang Medical Association
8. Renhuang Pharmaceuticals Exhibits All-Natural Products at the 107th China Import and Export Fair
9. Renhuang Announces Successful Preliminary Review of Its Patent Application for Schisandra Total Lignin Extraction Method
10. Renhuang Appoints PricewaterhouseCoopers to Develop a SOX 404 Compliance Program
11. Renhuang Schedules Conference Call to Discuss FY 2010 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013 Sequent Medical, ... for the SL ("Single Layer") family of WEB ® ... release of these new models in select neurovascular centers ... and superior navigability that will enable physicians to treat ... The SL configurations are made possible by ...
(Date:5/20/2013)... ATLANTA , May 20, 2013  Atlantic ... developed and is commercializing a unique technology to ... founder and President, Anthony Soscia ... the Atlanta Business Chronicle ,s Health-Care Heroes ... Atlanta Business Chronicle to honor individuals and ...
(Date:5/20/2013)... 20, 2013 Enrollment of patients with Type ... dose-finding clinical trial of product candidate NewMet ™, ... for Type 2 diabetes. Elcelyx expects to complete enrollment ... June. Results of the trial,s primary endpoint of change ... and the read-out for long-term glucose lowering and weight ...
Breaking Medicine Technology:Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4
... Karyopharm Therapeutics Inc., a leader in the new field of ... nuclear transport machinery plays an integral role in the regulation of ... disease. Karyopharm is focused on the discovery and development of novel ... n uclear e xport (SINE) ...
... CLEVELAND, Nov. 3, 2010 From pill-sized cameras to radioactive ... Clinic,s Top 10 Medical Innovations for 2011 showcases new techniques, ... The list of breakthrough devices and therapies was selected ... unveiled during Cleveland Clinic,s 2010 Medical Innovation Summit. ...
Cached Medicine Technology:Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders 2Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders 3Cleveland Clinic Unveils Top 10 Medical Innovations for 2011 2Cleveland Clinic Unveils Top 10 Medical Innovations for 2011 3Cleveland Clinic Unveils Top 10 Medical Innovations for 2011 4
(Date:5/20/2013)... May 20, 2013 yurbuds®, maker of ... out, today announced the launch of its new Signature ... Series-Pete Jacobs, with more signature athletes to come. Created ... Signature Series ITE 100 is the perfect training partner ... ITE 100 features reflective, tangle-resistant Kevlar cords, premium sound ...
(Date:5/20/2013)... The judge overseeing pretrial proceedings in the federal ... female lawyers to be included in a plaintiffs’ leadership ... acknowledges the judge’s request, noting that its lawyers ... on Mirena side effects and how to file a ... of some female lawyers to the committee. This followed ...
(Date:5/20/2013)... WINSTON-SALEM, N.C. May 20, 2013 Nearly 20 ... in the U.S. are refused for transplant due to ... the kidney,s filtering units to the organ going too ... of being discarded, these organs could be "recycled" to ... Researchers at Wake Forest Baptist Medical Center and colleagues, ...
(Date:5/20/2013)... Amsterdam, NL, 20 May 2013 While Huntington,s ... community anticipates that new disease-modifying therapies in development ... success of HD research depends upon the identification ... and evaluate therapies, and these biomarkers may eventually ... Biomarkers could be especially helpful to monitor changes ...
(Date:5/20/2013)... Dorland Health, a division of ... annual Case In Point Platinum Awards, recognizing outstanding ... the system is patient- and family-centric, safe and ... creative work across the healthcare system that is ... of care through effective care coordination across the ...
Breaking Medicine News(10 mins):Health News:yurbuds Expands Best-Selling Lines with Innovative New Products 2Health News:Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP 2Health News:Study suggests new source of kidneys for transplant 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 3Health News:Dorland Health Announces the 2013 Case In Point Platinum Awards Winners 2
... Bill to Protect Patient Access WASHINGTON, April 3 ... testing and reduce the physical and economic burden of ... Fracture Prevention and Osteoporosis Testing Act of 2009," (S. ... Olympia Snowe (R-ME) introduced the Senate version and Representatives ...
... IP - Over $2,200 In Donations Raised to ... photographer and philanthropist is taking his personal experience ... raise awareness for the nonprofit Innocence Project ... Mr. Verger for using his considerable talents to ...
... Don Jones, President of the California Association ... California Congressional Delegation today to join him in ... urgent need for health care reform in the ... the National Association of Health Underwriters, the California ...
... dose delivered by cardiac CT angiography by 39% in adult ... performed at the University of Erlangen in Erlangen, Germany. ... or less, who underwent cardiac CT angiography either using a ... that the effective radiation dose for patients scanned with 120 ...
... The U.S. Patent and Trademark Office is reviewing ... to use saliva as a non-invasive way to ... undergo transplants. , Associate Professor of Pharmacy Fatemeh ... measure levels of immunosuppressive agents such as cyclosporine, ...
... environment in which hospital budgets are tight, debts ... Information Systems (SIS) continues to invest in perioperative ... reduce costs, improve patient safety and ensure compliance.(Logo: ... )The current economic downturn is making it extremely ...
Cached Medicine News:Health News:Access to Osteoporosis Testing for Americans in Jeopardy 2Health News:Access to Osteoporosis Testing for Americans in Jeopardy 3Health News:Access to Osteoporosis Testing for Americans in Jeopardy 4Health News:Access to Osteoporosis Testing for Americans in Jeopardy 5Health News:Acclaimed New England Photographer Donald Verger Holds 'Faces of Innocence' Charity Event for the Innocence Project 2Health News:Patent pending for pain-free method of monitoring drug levels in transplant patients 2Health News:SIS Continues to Innovate and Maintain Focus on Interoperability 2Health News:SIS Continues to Innovate and Maintain Focus on Interoperability 3
For the quantitative determination of aspartate aminotransferase in serum. Optimized IFCC procedure without P-5'-P. 500 IU/L at 37C linearity....
The Definitive automated slide stainer is an industry standard. The Definitive allows automated slide staining in a compact, self-contained and easy-to use package....
... is an "assembly-line worker" for routine staining ... laboratories. Programmable continuous slide stainer for routine ... slides in short time. Its large number ... continuous working principle provides a high throughput. ...
HMS 760 Robot Stainer. Version includes display....
Medicine Products: